Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dørum

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|August 14, 1998
Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene statusB Smith-Sørensen, J Kaern, R Holm, et al.
Anticancer Research|July 1, 1996
Inherited predisposition to breast carcinoma. Results of first round examination of 537 women at riskA Saetersdal, A Dørum, K Heimdal, et al.
Clinical and Experimental Immunology|March 18, 2006
Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation techniqueS E Monstad, A Storstein, A Dørum, et al.
British Journal of Cancer|October 13, 2004
BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control studyT Bjørge, A K Lie, E Hovig, et al.
The New England Journal of Medicine|August 13, 1998
Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study GroupS A Narod, H Risch, R Moslehi, et al.
Acta Obstetricia Et Gynecologica Scandinavica|November 30, 1999
Prospectively detected cancer in familial breast/ovarian cancer screeningA Dørum, K Heimdal, K Løvslett, et al.
Journal of Medical Genetics|April 17, 2008
Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancersD G Evans, K N Gaarenstroom, D Stirling, et al.
Human Mutation|March 3, 1998
Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screeningT I Andersen, H G Eiken, F Couch, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testingA Dørum, P Møller, E J Kamsteeg, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Inherited breast carcinoma--prospective findings in 1,194 women at riskP Møller, L Maehle, K Heimdal, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|August 14, 1998
Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene statusB Smith-Sørensen, J Kaern, R Holm, et al.
Anticancer Research|July 1, 1996
Inherited predisposition to breast carcinoma. Results of first round examination of 537 women at riskA Saetersdal, A Dørum, K Heimdal, et al.
Clinical and Experimental Immunology|March 18, 2006
Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation techniqueS E Monstad, A Storstein, A Dørum, et al.
British Journal of Cancer|October 13, 2004
BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control studyT Bjørge, A K Lie, E Hovig, et al.
The New England Journal of Medicine|August 13, 1998
Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study GroupS A Narod, H Risch, R Moslehi, et al.
Acta Obstetricia Et Gynecologica Scandinavica|November 30, 1999
Prospectively detected cancer in familial breast/ovarian cancer screeningA Dørum, K Heimdal, K Løvslett, et al.
Journal of Medical Genetics|April 17, 2008
Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancersD G Evans, K N Gaarenstroom, D Stirling, et al.
Human Mutation|March 3, 1998
Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screeningT I Andersen, H G Eiken, F Couch, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testingA Dørum, P Møller, E J Kamsteeg, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Inherited breast carcinoma--prospective findings in 1,194 women at riskP Møller, L Maehle, K Heimdal, et al.
Pageof 3